jason hsu, md: prp vs anti vegf in patients lost to follow up
Published 6 years ago • 254 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
1:36
jason hsu, md: tackling treatment adherence in patients with diabetic retinopathy
-
4:08
jason hsu, md: short term outcomes of switching from aflibercept to ranibizumab in patients with nam
-
2:27
hossein ameri, md, phd: pan retinal photocoagulation versus anti-vegf
-
6:41
asrs 2020: diabetic retinopathy progression in anti-vegf versus fa implant
-
1:18
lloyd clark, md: choosing between anti-vegf therapies
-
3:23
jennifer sun, md: drcr anti-vegf algorithm improves pdr outcomes through 2 years
-
2:16
the utility of next-generation sequencing for multiple myeloma
-
1:14
rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
0:47
the role of antiphospholipid antibodies in scd
-
1:34
dynamic follow-up of smm can identify patients at high risk of progression
-
3:17
a pharmacoeconomic analysis of multiple myeloma treatment
-
3:17
the vascular surgeon -- the complete vascular specialist
-
1:24
the safety and efficacy of elotuzumab for the treatment of multiple myeloma
-
12:26
new immune-based therapies for multiple myeloma
-
5:30
february 2018 jvs editor summary
-
1:50
are we moving away from transplantation for the treatment of myeloma?
-
2:46
hss researchers discover immune cell dysfunction linked to photosensitivity
-
5:20
may 2021 jvs-vl editor summary
-
3:19
the complete vascular specialist